Open AccessAre there any differences among psoriasis, psoriatic arthritis and rheumatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors?
Author(s) -
Özlem Özkul,
Ayten Yazıcı,
Aysun Şikar Aktürk,
Duygu Temiz Karadağ,
Ö. Özdemir Işık,
Senem Tekeoğlu,
Ayşe Çefle
Publication year - 2019
Publication title -
european journal of rheumatology :/european journal of rheumatology
Language(s) - English
Resource type - Journals
eISSN - 2147-9720
pISSN - 2148-4279
DOI - 10.5152/eurjrheum.2019.19029
Subject(s) - medicine , psoriasis , metabolic syndrome , psoriatic arthritis , rheumatoid arthritis , insulin resistance , diabetes mellitus , arthritis , gastroenterology , dermatology , obesity , endocrinology
Although the frequency of metabolic syndrome has been studied separately in psoriasis, psoriatic arthritis (PsA), and rheumatoid arthritis (RA) patients, there is no study that compares the prevalence of metabolic syndrome in all three diseases. The purpose of this study is to evaluate the relationship between metabolic syndrome (MetS) and chronic low-grade inflammatory diseases, and to determine the frequency of MetS and insulin resistance in psoriasis and PsA as compared to RA.